CBMX $3.45 + $.28 1.0 MM float, CEO said turning cash flow positive soon
Okay. And then 1 last question for Scott. Do you have a breakeven sales number that you're working with?
Scott R. Burell - Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary
Yes. We're not providing forward-looking estimates at this time other than just what we've talked about before, which is this strategy of focusing on the prenatal markets and on the CMAs, those are the highest reimbursed tests that we perform. They carry the best gross margin of any of our tests, and that's where all of the growth is coming right now. So we're excited about maximizing that opportunity and I think in the relative short term, turning around that breakeven point relatively quickly. But that's probably about as much as we can comment at this time.
